Annual Drug Patent Expirations for DYANAVEL+XR+20
Dyanavel Xr 20 is a drug marketed by Tris Pharma Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has nineteen patent family members in fourteen countries.
The generic ingredient in DYANAVEL XR 20 is amphetamine; amphetamine aspartate/dextroamphetamine sulfate. One supplier is listed for this compound. Additional details are available on the amphetamine; amphetamine aspartate/dextroamphetamine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
